At MOCA’s Annual Meeting on May 22, 2018, MOCA provided a total of $775,000 to ovarian cancer researchers. We awarded $675,000 to five ovarian cancer research projects developed by Minnesota researchers.
We also awarded $100,000 to two researchers as part of our National Early Detection Research Awards. MOCA is proud to say that we’ve now provided more than $8 million in ovarian cancer research funding – thanks to supporters like you.
At our meeting, we heard from our keynote speaker and 2018 MOCA-funded researcher, Dr. Robert Bast from M.D. Anderson.
The 2018 MOCA-funded researchers include:
2018 Minnesota Research Projects:
- Martina Bazzaro, Ph.D. University of Minnesota. “Targeting of mitochondrial activity to prevent and treat recurrent ovarian cancer.” $75,000 for one year. Spin it Teal Research Award.
- Carol Lange, Ph.D. and Laura Mauro, Ph.D. University of Minnesota. “Targeting DNA damage sensing protein kinases in hereditary ovarian cancer. $200,000 for two years.
- Swayam Prabha, Ph.D., MBA. University of Minnesota. “Glycoengineered mesenchymal stem cells for combination chemo and immunotherapy of ovarian cancer. $100,000 for one year.
- Viji Shridhar, Ph.D. Mayo Clinic. “Targeting LRRC15 to inhibit metastasis and recurrence of ovarian cancer.” $200,000 for two years.
- Bruce Walcheck, Ph.D. University of Minnesota. “Engineered natural killer cells expressing chimeric CD64 as a cancer immunotherapy.” $100,000 for one year.
2018 National Early Detection Research Awards:
- Robert Bast, M.D. M.D. Anderson. “Serum autoantibodies for detection of early-stage ovarian cancer.” $50,000 for one year.
- Haiwei Gu, Ph.D. Arizona State University. “Metabolomics diagnosis of ovarian cancer.” $50,000 for one year.
Couldn’t make our meeting? You can watch the researcher presentations here: